At least one executive from the Management Team of Eurocine Vaccines will be present at this partnering conference to meet and discuss the latest development in nasal vaccination and specifically present recent results from the clinical study with Immunose™ FLU – our first candidate based on the technology platform Endocine™.

If you plan attending the conference and would like to schedule a meeting please register directly in the partnering system here =>

We look forward to meeting you in Amsterdam.

—–

A couple of years ago our CEO was interviewed about the new partnering strategy at Bio Europe Spring. Hear him here;